Jul 8 • General discussion
CVS Caremark Formulary Decision
Effective July 1, 2025, CVS Caremark—the pharmacy benefits management division (or the part of the company that helps manage prescription drug coverage) of CVS Health, stopped covering Zepbound as a preferred obesity management medicine on some insurance plans.
Patients and healthcare providers should be able to choose the medicine that best fits a person’s health needs—not be limited to just one option because of formulary (or lists of prescription medicines that your health insurance plan agrees to help pay for) decisions.
Text "Rx" to 85099 to receive updates if you were impacted by the CVS Caremark decision. This site will continuously be updated as new information evolves.
Your healthcare provider may be able to submit a prior authorization with a letter of medical necessity to your insurance plan. If your prior authorization is denied, your healthcare provider can submit an appeal.
Use this template to start the conversation with your healthcare provider to stay on Zepbound. This template is intended for your healthcare provider to complete and submit on your behalf.
Click here to access more information on filling an appeal:
If you or someone you know has been affected by this change, please comment below. Your experience matters—and sharing it may help others navigate their options. 💬👇
0
0 comments
CVS Caremark Formulary Decision
skool.com/glp-1-guidebook-4988
GLP-1 success starts here.
Led by a PharmD, CNC, WLS—get tools, gain clarity, and support to build habits and hit goals.
Join now!
Powered by